Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2019 | 1 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Nuclear Medicine and Wall Street: An Evolving Relationship.
J Nucl Med. 2019 Sep;60(Suppl 2):20S-24S. doi: 10.2967/jnumed.118.220798.
J Nucl Med. 2019.
PMID: 31481585
Free article.
Review.
Cascade genetic testing for hereditary cancer syndromes: a review of barriers and breakthroughs.
Levine R, Kahn RM, Perez L, Brewer J, Ratner S, Li X, Yeoshoua E, Frey MK.
Levine R, et al.
Fam Cancer. 2024 Mar 26. doi: 10.1007/s10689-024-00373-4. Online ahead of print.
Fam Cancer. 2024.
PMID: 38530571
Review.
Item in Clipboard
Clinical History of the Theranostic Radionuclide Approach to Neuroendocrine Tumors and Other Types of Cancer: Historical Review Based on an Interview of Eric P. Krenning by Rachel Levine.
Levine R, Krenning EP.
Levine R, et al.
J Nucl Med. 2017 Sep;58(Suppl 2):3S-9S. doi: 10.2967/jnumed.116.186502.
J Nucl Med. 2017.
PMID: 28864612
Free article.
This article provides a review of the evolution and development of the theranostic radionuclide approach to the management of neuroendocrine tumors, as described by the inventor of this technique, Eric P. Krenning, in an interview with Rachel Levine....
This article provides a review of the evolution and development of the theranostic radionuclide approach to the management of neuroendocrine …
Item in Clipboard
Cite
Cite